Paula Ko, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1207 N Scott St, Wilmington, DE 19806 Phone: 302-652-3353 Fax: 302-656-9979 |
Dr. Sharon S. Lehman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 |
News Archive
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
For years, researchers and patients have hoped that embryonic stem cells (ESCs)-capable of forming nearly any cell type in the body-could provide insight into numerous diseases perhaps even be used to treat them. Yet progress has been hampered by the inability to transfer research and tools from mouse ESC studies to their human counterparts, in part because human ESCs are "primed" and slightly less plastic than the mouse cells.
A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.
Researchers demonstrated the success of a fully implantable wireless medical device called a stentrode brain-computer interface designed to improve functional independence in patients with severe paralysis.
› Verified 1 days ago